New Products

Exuviance Masque and Facial

NeoStrata Company, Inc. launched two new skin rejuvenating masks to its anti-aging family of products. Exuviance Bionic Oxygen Facial is oxygenating facial that infuses skin with a restorative boost of radiance to energize and detoxify stressed skin. A triple oxygenating blend delivers an infusion of molecular Oxygen to detoxify and eliminate aging dullness, stimulate vital cellular energy and provide essential support for optimal collagen levels. The Bionic Complex adds extra youth-promoting benefits, restoring a translucent radiance, suppleness, and smooth silky softness to the complexion. Exuviance Pigment Lifting Masque is formulated with concentrated brighteners to diminish the look of dark spots and uneven pigmentation for a more even tone. Patented NeoGlucosamine® exfoliates skin, helping break up existing dark spots and creating more even pigment and tone. Vitamin C takes the brightening process one step further, helping to diminish the look of existing pigmentation while also helping prevent the formation of new spots. Exuviance.com

Goldfaden’s Plant Profusion Anti-Aging Line

GOLDFADEN MD Plant Profusion collection combines potent skin tightening, strengthening and hydrating agents that work together to diminish the appearance of fine lines and sagging skin on the face, around the eyes, and on the neck and décolleté. Detoxifying enzymes protect against DNA damage and stimulate collagen synthesis. The collection features GOLDFADEN MD Plant Profusion Extract Complex, PURFLORA, a proprietary complex blend. PURFLORA is clinically proven to effectively rejuvenate the skin by increasing cell turnover, reducing inflammation and improving luminosity to reveal a fresher, smoother, more radiant looking skin tone. The Collection includes a Supreme Serum, Energetic Eye Cream, Regenerative Night Cream, and Lifting Neck Cream. Goldfadenmd.com

Therapeutic Focus: Skin Cancer

FDA Requires Label Change for Picato

The FDA released a Drug Safety Communication to warn about reports of severe allergic reactions and herpes zoster (shingles) associated with the use of Picato gel (ingenol mebutate), approved to treat actinic keratosis (AK).

FDA said it also received reports of cases involving severe eye injuries and skin reactions associated with the application of Picato gel. Some cases were associated with Picato gel not being used according to the instructions for use on the label. As a result, the FDA is requiring changes to the label to warn about these new safety risks and to provide additional instructions on the safe and appropriate application of the product. The full alert is on the FDA’s website.

ASDS/ASDSA Accepts ‘Call to Action’ on Skin Cancer Prevention

The American Society for Dermatologic Surgery (ASDS) actively supports measures to fight skin cancer set forth in the Skin Cancer Prevention Progress Report recently issued by the Centers for Disease Control and Prevention.

The Progress Report builds upon last summer’s Call to Action to Prevent Skin Cancer issued by then Acting (now Deputy) Surgeon General Boris Lushniak, a board-certified dermatologist. His Call to Action sought to establish skin cancer prevention as a national priority while identifying strategies to reverse the trend of rising skin cancer rates. The Call to Action identified five goals to combat skin cancer:


• Increase opportunities for sun protection in outdoor settings.
• Provide individuals with the information they need to make informed, healthy choices about UV exposure.

• Promote policies that advance the national goal of preventing skin cancer.

• Reduce harms from indoor tanning.

• Strengthen research, surveillance, monitoring, and evaluation related to skin cancer prevention. n